CB1a, Cecropin-B1a

General Information


DCTPep ID  DCTPep01139

Peptide Name   CB1a, Cecropin-B1a

Sequence  KWKVFKKIEKKWKVFKKIEKAGPKWKVFKKIEK

Sequence Length  33

UniProt ID  P01508 

PubChem CID  Not available

Origin  Not available

Type  Synthetic peptide

Classification

  

ACP Tumor active peptide



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
NCI-H520 Lung squamous cell carcinoma IC50=22.7±0.2 µM MTT assay 48 h 1
NCI-H661 Lung squamous cell carcinoma IC50=35.9±0.2 µM MTT assay 48 h 1
CCRF-CEM Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia IC50=4.4±0.3 µM MTT assay 48 h 1
AGS Gastric adenocarcinoma IC50=5.6±0.5 µM MTT assay 48 h 1
HL-60 Adult acute myeloid leukemia; Acute myeloid leukemia IC50=6.7±1.1 µM MTT assay 48 h 1

Hemolytic Activity  Human erythrocytes: 18% Hemolysis=200 µM

Normal (non-cancerous) Cytotoxicity  RPMI-7666: IC50>100 µM; NIH 3T3: IC50>50 µM; WI-38: IC50>100 µM

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  2IGR 

Predicted Structure  DCTPep01139

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C208H335N51O40

Absent amino acids  CDHLMNQRSTY

Theoretical pI  10.44

Acidic residues  3

Basic residues  15

Polar residues  1

Molecular weight (Average)  4190.27

Molecular weight (Monoisotopic)  4187.57

Common amino acids  K

Net charge  12

Instability index (II)  20.54

Aliphatic index  64.85

Grand average of hydropathicity (GRAVY)  -1.133

Half Life 
  1.3 hours (mammalian reticulocytes, in vitro).
  3 min (yeast, in vivo).
  3 min (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 16500
  Abs 0.1% (=1 g/l) 3.938

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19428759

Title  Structure and function of a custom anticancer peptide, CB1a

Doi 10.1016/j.peptides.2009.02.004

Year  2009

Patent

Patent ID CN108546285A

Patent Title  Anticancer biological active peptide CB1a and applications thereof

Other Iinformation  Patent Application; Family: 2s / 2ex; Family Jurisdictions: CN; Legal Status: Active; Application No: 201810184631; Filed: Mar 7, 2018; Published: Sep 18, 2018; Earliest Priority: Mar 7, 2018; Granted: Oct 26, 2021

Other Published ID  CN108546285B 




DCTPep is developed by Dr.Zheng's team.